Singapore markets close in 3 hours 10 minutes

Crinetics Pharmaceuticals, Inc. (CRNX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
46.50-0.70 (-1.48%)
At close: 04:00PM EDT
46.50 0.00 (0.00%)
After hours: 04:16PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-214,529
-214,529
-163,918
-107,641
-73,812
Depreciation & amortisation
1,098
1,098
983
922
948
Stock-based compensation
40,937
40,937
28,268
17,352
10,427
Change in working capital
8,044
8,044
18,612
1,096
376
Accounts receivable
14,648
14,648
10,994
6,293
2,723
Accounts payable
-
-
-
6,293
2,723
Other working capital
-170,995
-170,995
-116,861
-89,024
-62,213
Other non-cash items
-790
-790
406
-739
261
Net cash provided by operating activities
-166,307
-166,307
-115,205
-88,588
-62,027
Cash flows from investing activities
Investments in property, plant and equipment
-4,688
-4,688
-1,656
-436
-186
Purchases of investments
-532,857
-532,857
-329,817
-125,404
-135,592
Sales/maturities of investments
337,132
337,132
157,493
69,357
135,995
Net cash used for investing activities
-200,413
-200,413
-173,980
-56,483
217
Cash flows from financing activities
Debt repayment
0
-
-
-
-
Common stock issued
369,019
369,019
117,242
249,542
114,283
Common stock repurchased
-
-
-
0
0
Net cash used provided by (used for) financing activities
388,944
388,944
121,963
252,679
114,571
Net change in cash
22,224
22,224
-167,222
107,608
52,761
Cash at beginning of period
33,973
33,973
201,195
93,587
40,826
Cash at end of period
56,197
56,197
33,973
201,195
93,587
Free cash flow
Operating cash flow
-166,307
-166,307
-115,205
-88,588
-62,027
Capital expenditure
-4,688
-4,688
-1,656
-436
-186
Free cash flow
-170,995
-170,995
-116,861
-89,024
-62,213